113 related articles for article (PubMed ID: 32272365)
1. Synthesis and anti-hepaticfibrosis of glycyrrhetinic acid derivatives with inhibiting COX-2.
Zhang Q; Mohammed EAH; Wang Y; Bai Z; Zhao Q; He D; Wang Z
Bioorg Chem; 2020 Jun; 99():103804. PubMed ID: 32272365
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and anti-inflammatory activities of glycyrrhetinic acid derivatives containing disulfide bond.
Zhang Q; Wang Y; Wang Z; Mohammed EAH; Zhao Q; He D; Wang Z
Bioorg Chem; 2022 Feb; 119():105542. PubMed ID: 34902645
[TBL] [Abstract][Full Text] [Related]
3. Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells.
Yu HX; Yao Y; Bu FT; Chen Y; Wu YT; Yang Y; Chen X; Zhu Y; Wang Q; Pan XY; Meng XM; Huang C; Li J
Mol Immunol; 2019 Mar; 107():29-40. PubMed ID: 30639476
[TBL] [Abstract][Full Text] [Related]
4. Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways.
Huang Q; Zhang X; Bai F; Nie J; Wen S; Wei Y; Wei J; Huang R; He M; Lu Z; Lin X
Int Immunopharmacol; 2019 Jan; 66():41-51. PubMed ID: 30419452
[TBL] [Abstract][Full Text] [Related]
5. Gan Shen Fu Fang ameliorates liver fibrosis
Du QH; Zhang CJ; Li WH; Mu Y; Xu Y; Lowe S; Han L; Yu X; Wang SY; Li Y; Li J
World J Gastroenterol; 2020 Jun; 26(21):2810-2820. PubMed ID: 32550756
[TBL] [Abstract][Full Text] [Related]
6. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference.
Jiang Y; Wang C; Li YY; Wang XC; An JD; Wang YJ; Wang XJ
J Ethnopharmacol; 2014 Dec; 158 Pt A():230-8. PubMed ID: 25456431
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis
Zou GL; Zuo S; Lu S; Hu RH; Lu YY; Yang J; Deng KS; Wu YT; Mu M; Zhu JJ; Zeng JZ; Zhang BF; Wu X; Zhao XK; Li HY
World J Gastroenterol; 2019 Aug; 25(30):4222-4234. PubMed ID: 31435175
[TBL] [Abstract][Full Text] [Related]
8. Repression of liver cirrhosis achieved by inhibitory effect of miR-454 on hepatic stellate cells activation and proliferation via Wnt10a.
Wang YZ; Zhang W; Wang YH; Fu XL; Xue CQ
J Biochem; 2019 Apr; 165(4):361-367. PubMed ID: 30535384
[TBL] [Abstract][Full Text] [Related]
9. Anti-hepatic fibrosis effects of a novel turtle shell decoction by inhibiting hepatic stellate cell proliferation and blocking TGF-β1/Smad signaling pathway in rats.
Bai G; Yan G; Wang G; Wan P; Zhang R
Oncol Rep; 2016 Nov; 36(5):2902-2910. PubMed ID: 27633729
[TBL] [Abstract][Full Text] [Related]
10. Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats.
Li J; Liu P; Zhang R; Cao L; Qian H; Liao J; Xu W; Wu M; Yin Z
J Ethnopharmacol; 2011 Sep; 137(1):714-23. PubMed ID: 21726622
[TBL] [Abstract][Full Text] [Related]
11. Schisandrin B attenuates CCl
Chen Q; Zhang H; Cao Y; Li Y; Sun S; Zhang J; Zhang G
Drug Des Devel Ther; 2017; 11():2179-2191. PubMed ID: 28794616
[TBL] [Abstract][Full Text] [Related]
12. Dicliptera Chinensis polysaccharides target TGF-β/Smad pathway and inhibit stellate cells activation in rats with dimethylnitrosamine-induced hepatic fibrosis.
Zhang X; Zhang J; Jia L; Xiao S
Cell Mol Biol (Noisy-le-grand); 2016 Jan; 62(1):99-103. PubMed ID: 26828995
[TBL] [Abstract][Full Text] [Related]
13. Ampelopsin attenuates carbon tetrachloride-induced mouse liver fibrosis and hepatic stellate cell activation associated with the SIRT1/TGF-β1/Smad3 and autophagy pathway.
Ma JQ; Sun YZ; Ming QL; Tian ZK; Yang HX; Liu CM
Int Immunopharmacol; 2019 Dec; 77():105984. PubMed ID: 31677501
[TBL] [Abstract][Full Text] [Related]
14. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl
Sun H; Chen G; Wen B; Sun J; An H; Pang J; Xu W; Yang X; He S
J Pharmacol Sci; 2018 Mar; 136(3):133-141. PubMed ID: 29501581
[TBL] [Abstract][Full Text] [Related]
15. Moniliformediquinone as a potential therapeutic agent, inactivation of hepatic stellate cell and inhibition of liver fibrosis in vivo.
Tseng TH; Lin WL; Chen ZH; Lee YJ; Shie MS; Lee KF; Shen CH; Kuo HC
J Transl Med; 2016 Sep; 14(1):263. PubMed ID: 27612633
[TBL] [Abstract][Full Text] [Related]
16. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
[TBL] [Abstract][Full Text] [Related]
17. LEFTY2 alleviates hepatic stellate cell activation and liver fibrosis by regulating the TGF-β1/Smad3 pathway.
Yang YR; Bu FT; Yang Y; Li H; Huang C; Meng XM; Zhang L; Lv XW; Li J
Mol Immunol; 2020 Oct; 126():31-39. PubMed ID: 32745796
[TBL] [Abstract][Full Text] [Related]
18. SENP2 alleviates CCl
Bu FT; Chen Y; Yu HX; Chen X; Yang Y; Pan XY; Wang Q; Wu YT; Huang C; Meng XM; Li J
Toxicol Lett; 2018 Jun; 289():86-98. PubMed ID: 29535048
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of hydrogen sulfide on oxidative stress and fibrosis in hepatic stellate cells.
Fan HN; Wang HJ; Yang-Dan CR; Ren L; Wang C; Li YF; Deng Y
Mol Med Rep; 2013 Jan; 7(1):247-53. PubMed ID: 23129058
[TBL] [Abstract][Full Text] [Related]
20. Thymosin β4 suppresses CCl
Li H; Li Q; Zhang X; Zheng X; Zhang Q; Hao Z
J Gene Med; 2018 Sep; 20(9):e3043. PubMed ID: 29972714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
